Audience Q&A

Every Cell & Gene Live dedicates time to answering real-time questions from the audience. During “Building An In-House Cell & Gene Manufacturing Facility – Best Practices & Lessons Learned,” panelists Will Junker, Head of Vector Manufacturing Quality at Kite Pharma and Mitch Lower, SVP of Technical Operations at Kriya Therapeutics provided thoughtful and detailed responses to audience questions on everything from utilizing pre-fab units, exit strategies, risk mitigation, and much more.